Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2149 (LINC02149)

Target
LINC02149
Molecular classification
Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2149, known as LINC02149, is a member of the lincRNA class of RNA molecules, which are defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap annotated coding genes [1][5]. Like other lincRNAs, LINC02149 is not translated into protein and may play roles in the regulation of gene expression, either by influencing chromatin structure, modulating transcription, or interacting with protein or RNA partners[5]. At present, there are no documented therapeutic agents, validated direct disease associations, or established functions specific to LINC02149 in the provided literature or major genic databases, though the broad lincRNA class contributes to gene expression regulation and potentially to disease[5].

Other names
LINC02149
02

Biological functions

Putative gene expression regulation (based on known lincRNA functions)Chromatin remodeling (by analogy with other lincRNAs)Regulation of neighboring gene expression (by analogy)
03

Disease associations

Other (the specific association with major disease categories is not established; lincRNAs in general are implicated in cancer and other regulatory diseases, but no direct evidence for LINC02149 found in current results)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2149 (LINC02149).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2149 (LINC02149).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call